Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation CENPF_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-25398 | CENPF | down-regulates | FGF9 | represses | R-1767 | 4 | 1 | Drugs (2) |
CMF-25400 | CENPF | up-regulates | RXRA | activates | R-3213 | 13 | 2 | Drugs (12) Regulator Drugs (2)Regulon Drugs (10)SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, BHQ-880, ABITUZUMAB |
CMF-25402 | CENPF | down-regulates | ALX4 | represses | R-2914 | 20 | 2 | Drugs (19) Regulator Drugs (0)Regulon Drugs (19)BEVACIZUMAB, CONBERCEPT, AMG-780, MEDI-3617, PEGAPTANIB SODIUM, ENIBARCIMAB, F16SIP 131I, TREBANANIB, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, F16IL2, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, CVX-060, ABICIPAR PEGOL, NESVACUMAB, AFLIBERCEPT, BROLUCIZUMAB |
CMF-25404 | CENPF | down-regulates | GATA6 | represses | R-1253 | 18 | 1 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)AMG-780, MEDI-3617, ENIBARCIMAB, TREBANANIB, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-25408 | CENPF | down-regulates | TEF | represses | R-2660 | 15 | 3 | Drugs (1) |